Literature DB >> 11022396

Influence of chronic barbiturate administration on sleep apnea after hypersomnia presentation: case study.

J Takhar1, J Bishop.   

Abstract

When sleepiness is excessive, undesirable, inappropriate or unexplained, it often indicates a clinical disorder that is generically termed hypersomnia. One of the leading causes of hypersomnia is sleep apnea. We present the case of a 44-year-old woman with a history of bipolar spectrum disorder and epilepsy who initially showed evidence of hypersomnia. The hypersomnia settled with changes to her medication, but the patient was subsequently found to have severe obstructive sleep apnea. The relation between the patient's medication and sleep apnea is discussed, and the possible respiratory-suppressant effects of chronic barbiturate treatment are considered. The role of other evoking factors within the context of this case and the mechanisms by which drug interactions and psychotropic treatment may worsen, obscure or perpetuate sleep apnea are also examined.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11022396      PMCID: PMC1407734     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  8 in total

1.  The effects of anesthetic drugs and disease on the chemical regulation of ventilation.

Authors:  E R Kafer; H M Marsh
Journal:  Int Anesthesiol Clin       Date:  1977

2.  Four cases of obstructive sleep apnea associated with treatment-resistant mania.

Authors:  S M Strakowski; J I Hudson; P E Keck; D R Wilson; F R Frankenburg; J E Alpert; G C Teschke; M Tohen
Journal:  J Clin Psychiatry       Date:  1991-04       Impact factor: 4.384

3.  Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril).

Authors:  M V Lambert; J M Bird
Journal:  Seizure       Date:  1997-06       Impact factor: 3.184

4.  [Epilepsy and sleep apnea syndrome].

Authors:  D Ezpeleta; A García-Peña; R Peraita-Adrados
Journal:  Rev Neurol       Date:  1998-03       Impact factor: 0.870

5.  [Sleep apnea syndrome--serious complications in a female patient treated with psychopharmaceutic agents].

Authors:  E Horká; M Hrdlicka; M Morán; P Strnad; L Rektor
Journal:  Cas Lek Cesk       Date:  1993-03-22

6.  Effects of age on sleep apnea in men: I. Prevalence and severity.

Authors:  E O Bixler; A N Vgontzas; T Ten Have; K Tyson; A Kales
Journal:  Am J Respir Crit Care Med       Date:  1998-01       Impact factor: 21.405

7.  Valproic acid and plasma levels of phenobarbital.

Authors:  J Bruni; B J Wilder; R J Perchalski; E J Hammond; H J Villarreal
Journal:  Neurology       Date:  1980-01       Impact factor: 9.910

8.  Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes.

Authors:  W B Mendelson; D Garnett; J C Gillin
Journal:  J Nerv Ment Dis       Date:  1981-04       Impact factor: 2.254

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.